Noxilizer, Inc.

The Noxilizer team has been on the move the last two weeks. Attending and exhibiting at the PDA Universe of Prefilled Syringes and Injection Devices in Phoenix and Partnership Opportunities in Drug Delivery (PODD) in Boston. There have been productive meetings with current and prospective customers on their products and the benefits of NO2 sterilization. NO2 is the leading sterilization method for these important combination products.

Noxilizer will be exhibiting at PODD next week in Boston (Booth 45). We look forward to talking about the benefits of nitrogen dioxide sterilization and why NO2 is the first choice for many drug delivery devices.

This is a great opportunity to meet in person. We will have Noxilizer NO2?technical experts on-site. Please contact Victoria Bonefont ([email protected]) to schedule a meeting. We look forward to seeing you at the Phoenix Convention Center (Booth 114).

FDA Approves Combination Product Using NO2?Sterilization The FDA recently approved a combination product using Noxilizer’s NO2?sterilization process. This is a biotech drug delivered in a prefilled syringe. The biotech company chose NO2?over other sterilization methods because of the ultra-low temperature sterilization process, minimum vacuum option and low to no residuals – all maintaining drug integrity. There are other products currently in review at the FDA and European Medicines Agency (EMA). More approvals to come! Please contact Noxilizer to discuss how NO2?sterilization may be the solution for your product.

Fermilab Hosts Medical Device Sterilization: Broadening the Possibilities in Batavia, IL (and online) September 24-25, 2024. David Opie will be on?the Alternative Gasses Panel?on September 24 from 10:50am – 11:35am CT. You can register at https://lnkd.in/ehSMkn-X

Noxilizer to Present on September 17th?During AAMI Standards Week David Opie will be co-presenting on the?Compatibility of Materials Subject to Sterilization?(in the 8am – Noon ET timeframe). To learn more about AAMI, Sterilization Standards Week and this session, go to the?AAMI website at https://www.aami.org/.

There continues to be great interest in?alternative sterilization methods?as pharmaceutical, biotech and medical device companies move away from ethylene oxide (EO). Nitrogen dioxide (NO2) is the leading gas sterilization option. Below is the first of three industry meetings in September where you can learn more about how alternative gasses, like NO2, can be a sterilization solution for your company. Join Pharmaceutical, Biotech and Medical Device Sterilization Leaders on a Webinar on September 10, 2024 David Opie, PhD, SVP of R&D at Noxilizer, will be co-presenting on?Sterilization, Material Science and Packaging. Registration information for the?Industry Scientific Exchange on Alternative Sterilization Modalities Materials Impact?to follow in early September.

Noxilizer appoints Christopher A. Thatcher as new CEO June 5, 2024 Noxilizer’s Board of Directors announces the appointment of Christopher A. Thatcher as President & CEO effective May 13. He has also joined the Board of Directors. Chris brings a proven track record of experience in early-stage private and publicly held medical device companies, US and global markets, and commercial success in business-to-business and business-to-consumer environments... For more information click on the link below or go to https://lnkd.in/esPNN4U2

Meet Noxilizer in New York City, Boston and More to Come ? Noxilizer will be exhibiting at INTERPHEX April 16-18 (Booth 2143), Pre-filled Syringes East Coast April 23-24 and more conferences this spring and summer. Meet the NO2 experts to learn more about the first-choice sterilization method for pre-filled syringes and a leading alternative sterilization method for medical devices.